Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats

Neuroreport. 1997 May 27;8(8):1883-5. doi: 10.1097/00001756-199705260-00018.

Abstract

The aim of the present study was to examine the effects of nicotinamide, a co-factor in the electron transport chain, on the relationship between methamphetamine (MA)-induced striatal dopamine (DA) depletion and energy metabolism change. Four injections of MA (10 mg/kg, i.p.) at 2 h intervals resulted in decreases of 51% and 23%, respectively, in striatal DA and adenosine 5'-triphosphate (ATP) levels 5 days later. Nicotinamide (500 mg/kg, i.p.) treatment prior to each MA injection attenuated the reductions of striatal DA and ATP contents. Nicotinamide had no long-term effects on striatal DA and ATP levels. These findings suggest that energy impairment might play a role in MA-induced DAergic neurotoxicity in the striatum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Dopamine / metabolism*
  • Dopamine Uptake Inhibitors / antagonists & inhibitors*
  • Dopamine Uptake Inhibitors / pharmacology
  • Energy Metabolism / drug effects
  • Male
  • Methamphetamine / antagonists & inhibitors*
  • Methamphetamine / pharmacology
  • Neostriatum / drug effects
  • Neostriatum / metabolism*
  • Niacinamide / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Dopamine Uptake Inhibitors
  • Niacinamide
  • Methamphetamine
  • Adenosine Triphosphate
  • Dopamine